Polygenic modelling and machine learning approaches in pharmacogenomics: Importance in downstream analysis of genome‐wide association study data
British Journal of Clinical Pharmacology · 2025
DOI: 10.1111/bcp.15913 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Masaru Koido. Beteiligte Einrichtung: Laboratory of Complex Trait Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University …. Hauptthemen laut MEDLINE: Machine Learning, Genome-Wide Association Study, Pharmacogenetics, Multifactorial Inheritance. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS KAKENHI, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Genome‐wide association studies (GWAS) have identified genetic variations associated with adverse drug effects in pharmacogenomics (PGx) research. However, interpreting the biological implications of these associations remains a challenge. This review highlights 2 promising post‐GWAS methods for PGx. First, we discuss the polygenic architecture of the PGx traits, especially for drug‐induced liver injury. Experimental modelling using multiple donors' human primary hepatocytes and human liver organoids demonstrated the polygenic architecture of drug‐induced liver injury susceptibility and found biological vulnerability in genetically high‐risk tissue donors. Second, we discuss the challenges of interpreting the roles of variants in noncoding regions. Beyond methods involving expression quantitative trait locus analysis and massively parallel reporter assays, we suggest the use of in silico mutagenesis through machine learning methods to understand the roles of variants in transcriptional regulation. This review underscores the importance of these post‐GWAS methods in providing critical insights into PGx, potentially facilitating drug development and personalized treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Complex Trait Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Masaru Koido
Förderung
- JSPS KAKENHI
- Japan Society for the Promotion of Science
Zitieren
APA
Koido, M. (2025). Polygenic modelling and machine learning approaches in pharmacogenomics: Importance in downstream analysis of genome‐wide association study data. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15913
Vancouver
Koido M. Polygenic modelling and machine learning approaches in pharmacogenomics: Importance in downstream analysis of genome‐wide association study data. British Journal of Clinical Pharmacology. 2025. doi:10.1111/bcp.15913
BibTeX
@article{Koido2025,
author = {Koido, Masaru},
title = {Polygenic modelling and machine learning approaches in pharmacogenomics: Importance in downstream analysis of genome‐wide association study data},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1111/bcp.15913}
}
EUVIMED